1. Others
  2. Others
  3. Madrasin

Madrasin  (Synonyms: DDD00107587)

Cat. No.: HY-100236 Purity: 99.90%
COA Handling Instructions

Madrasin (DDD00107587) is a splicing inhibitor that prevents formation of both splicing intermediates and products in vitro and interferes with one or more early steps in the pathway of spliceosome assembly. Madrasin also can inhibit pre-mRNA splicing in vitro and modify splicing of endogenous pre-mRNA in cells.

For research use only. We do not sell to patients.

Madrasin Chemical Structure

Madrasin Chemical Structure

CAS No. : 374913-63-0

Size Price Stock Quantity
5 mg USD 79 In-stock
10 mg USD 119 In-stock
25 mg USD 238 In-stock
50 mg USD 396 In-stock
100 mg USD 660 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 7 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Madrasin purchased from MedChemExpress. Usage Cited in: Nucleic Acids Res. 2019 Sep 5;47(15):8239-8254.  [Abstract]

    Madrasin treatment leads to decrease of spliced POLR2A transcripts and accumulation of unspliced transcripts.

    Madrasin purchased from MedChemExpress. Usage Cited in: Nucleic Acids Res. 2019 Sep 5;47(15):8239-8254.  [Abstract]

    IF staining shows the loss of POLR2A protein after madrasin treatment. IF staining of POLR2A is performed after 24 h of Madrasin treatment at 30 uM. EU incorporation assay shows substantial reduction of newly transcribed RNA after Madrasin treatment. Assay is performed after 24 h of Madrasin treatment (30 μM).

    Madrasin purchased from MedChemExpress. Usage Cited in: Nucleic Acids Res. 2019 Sep 5;47(15):8239-8254.  [Abstract]

    Western blot shows loss of POLR2A protein in Madrasin-treated cells. Cells are harvested after Madrasin treatment (30 μM) for 24 h.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Madrasin (DDD00107587) is a splicing inhibitor that prevents formation of both splicing intermediates and products in vitro and interferes with one or more early steps in the pathway of spliceosome assembly. Madrasin also can inhibit pre-mRNA splicing in vitro and modify splicing of endogenous pre-mRNA in cells[1].

    IC50 & Target

    pre-mRNA splicing[1]

    In Vitro

    Madrasin (10-30 μM; 4-24 hours; HeLa cells) treatment inhibits the splicing of each of the RIOK3, BRD2, and Hsp40, MCL1, CCNA2, AURKA and p27 pre-mRNAs in both HeLa and HEK293 cells[1].
    Madrasin (10-30 μM; 4-24 hours; HeLa and HEK293 cells) treatment shows a dose- and time-dependent inhibitory effect on cell cycle progression[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    RT-PCR[1]

    Cell Line: HeLa cells
    Concentration: 10 μM, 20 μM, or 30 μM
    Incubation Time: 4 hours, 8 hours, or 24 hours
    Result: Increased in inhibition of pre-mRNA splicing.

    Cell Cycle Analysis[1]

    Cell Line: HeLa and HEK293 cells
    Concentration: 10 μM, 20 μM, or 30 μM
    Incubation Time: 4 hours, 8 hours, or 24 hours
    Result: In the presence of 10 μM 8 hours after treatment, the proportion of cells in G2, M, and S phases increased, with a concomitant decrease in the number of G1 phase cells. This effect increased over time, with >40% of cells in G2 and M phase and >50% in S phase 24 hours.
    Molecular Weight

    311.34

    Appearance

    Solid

    Formula

    C16H17N5O2

    CAS No.
    SMILES

    O=C1N=C(NC2=NC(C)=C3C=CC(OC)=CC3=N2)NC(C)=C1C

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : 2 mg/mL (6.42 mM; Need ultrasonic)

    H2O : < 0.1 mg/mL (insoluble)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.2119 mL 16.0596 mL 32.1192 mL
    5 mM 0.6424 mL 3.2119 mL 6.4238 mL
    10 mM --- --- ---
    *Please refer to the solubility information to select the appropriate solvent.
    Purity & Documentation

    Purity: 99.90%

    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Madrasin Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email Address *

    Phone Number *

     

    Organization Name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Madrasin
    Cat. No.:
    HY-100236
    Quantity:
    MCE Japan Authorized Agent: